← Back to Company DatabaseVisit Website
Foundation Medicine
Comprehensive genomic profiling for precision oncology.
AcquiredCambridge, MAFounded 2010
About
Foundation Medicine is a pioneer in comprehensive genomic profiling for cancer, offering tests that analyze tumors to identify actionable molecular alterations. Its FoundationOne CDx and FoundationOne Liquid CDx are FDA-approved companion diagnostics used by oncologists worldwide. The company was acquired by Roche in 2018 and serves as a key pillar in precision oncology.
Total Funding
$330MKey Product
FoundationOne CDx comprehensive genomic profilingGeography
North AmericaKey Investors
RocheGoogle VenturesKleiner Perkins
Focus Areas
DiagnosticsTreatment (Therapeutics)Data / Analytics
Technology
Genomics / SequencingLiquid Biopsy
Cancer Types
Pan-cancer
Last updated: Feb 4, 2026